Guideline Summary NGC (2016): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
Journal Title: Нирки - Year 2016, Vol 4, Issue 18
Abstract
National Institute for Health and Care Excellence (NICE) June 14, 2016 – Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR) External Web Site Policy: The U.S. Food and Drug Administration (FDA) has strengthened the existing warning about the risk of acute kidney injury for the type 2 diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR). Based on recent reports, they have revised the warnings in the drug labels to include information about acute kidney injury and added recommendations to minimize this risk.
Authors and Affiliations
Mariia Ivanova
Keywords
Related Articles
- EP ID EP207144
- DOI 10.22141/2307-1257.4.18.2016.84326
- Views 86
- Downloads 0
Kidney Transplantation on Children
.
Modern Principles of Nephroprevention and Renoprotective Effects of Low-Protein Diet Using Ketoanalogues of Essential Amino Acids in Patients with Chronic Kidney Disease
The article deals with one of the most pressing problems in nephrology — chronic kidney disease. Characteristics of risk factors for this disease, as well as the main directions of its treatment are provided. The importa...
Hyperuricemia and prognosis in chronic kidney disease
The ratio of uricemia, magnesia, quality of life and functional reserve of the kidneys in CKD has not been completely determined yet. These rates were analysed in 145 patients, depending on the CKD 1–5 stages. The dynami...
Relevance of the modern renal biomarkers use for the screening of early development of preeclampsia
Pre-eclampsia is a unique multi-system disorder that occurs during the second half of pregnancy and is characterized by the arterial hypertension and proteinuria manifesting by heterogeneous disorders and adversely affec...
New era of dialysis: expanded haemodialysis (HDx)
The article is addressed to practical physicians involved in renal replacement therapy, mainly haemodialysis (HD). The article presents a new method for haemodialysis — expanded haemodialysis, assesses its efficiency, an...